Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | -3 | -3 | -3 |
EBITDA | -9,089 | -9,882 | -22,770 | -7,493 |
EBIT | -9,093 | -9,886 | -22,774 | -7,496 |
Net Income | 1,715 | -11,359 | 6,001 | -2,418 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,961 | -7,444 | -7,605 | -10,919 |
Cash | 933 | 6,206 | 13,645 | 21,251 |
Basic Shares | 15,981 | 15,981 | 16,674 | 15,981 |
Annual Financials
| Values in thousands | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15 | -15 | -15 | -13 |
EBITDA | -22,365 | -11,502 | 3,705 | 1,398 |
EBIT | -22,381 | -11,518 | 3,689 | 1,383 |
Net Income | -20,302 | -11,580 | -2,894 | 1,384 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -16,227 | |||
Free Cash Flow | -23,744 | -12,484 | -7,747 | -1,159 |
Cash | 21,251 | 41,041 | 57,268 | 19 |
Basic Shares | 15,619 | 15,494 | 4,519 | 713 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-04-30 | $0.11 |
2024-01-31 | -$0.71 |
2023-10-31 | -$0.50 |
2023-07-31 | -$0.15 |
